AVKARE, LLC

AvKARE LLC specializes in the manufacturing of sterile and non-sterile pharmaceutical preparations, with deep expertise in the production of tablet formulations for high-volume government procurement. The company’s core capabilities include the end-to-end manufacturing of active pharmaceutical ingredients into finished dosage forms, particularly sustained-release tablets such as metformin HCl 24HR SA and angiotensin receptor blockers like telmisartan and valsartan. Their technical proficiency spans GMP-compliant production processes, batch consistency validation, and supply chain integrity for critical therapeutics used in military and veteran healthcare systems. AvKARE’s differentiation lies in its ability to reliably deliver complex, high-demand generic medications under strict federal quality and timing requirements, ensuring continuity of care for large-scale federal beneficiaries. The contractor maintains a strong, consistent relationship with the Department of Defense and the Department of Veterans Affairs, supplying essential medications to support active-duty personnel, retirees, and VA healthcare networks. Work for these agencies centers on national contract fulfillment of oral solid dosage forms, often under long-term agreements with option periods, indicating trusted, recurring procurement partnerships. DLA Troop Support serves as the primary logistics conduit, coordinating distribution of pharmaceuticals across military treatment facilities and deployed operations. AvKARE’s primary industry focus is pharmaceutical preparation manufacturing (NAICS 325412), with significant activity in medicinal and botanical manufacturing (325411), reflecting a dual focus on synthetic drug formulation and plant-derived therapeutics. The company is positioned as a reliable supplier of generic, high-volume oral medications critical to chronic disease management and preventive care within federal health systems. AvKARE LLC is a small business entity headquartered in Pulaski, Tennessee, with no public certifications on record. Its operational footprint is centered on domestic manufacturing and federal supply chain integration, serving as a key domestic source for mission-critical pharmaceuticals within the U.S. government healthcare ecosystem.